Genzyme fends off looming proxy fight – Boston Globe
By Dr. Matthew Watson
 Boston Globe | Genzyme fends off looming proxy fight Boston Globe Activist shareholder Carl C. Icahn has completed deals with two big Cambridge biotechnology companies — Biogen Idec and Genzyme. ... Genzyme, Icahn reach accord, ending proxy fightReuters (press release) Genzyme and Carl Icahn Reach AgreementMarketWatch (press release) Icahn withdraws Genzyme board nomineesFinancial Times Wall Street Journal -BusinessWeek -The Associated Press all 180 news articles » |
Uncategorized
Comments Off on Genzyme fends off looming proxy fight – Boston Globe |
June 10th, 2010
This author published 5852 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research